BRIEF-Abbott Receives Regulatory Approval For The First Denosumab Biosimilar In Thailand
Reuters
Aug 26
BRIEF-Abbott Receives Regulatory Approval For The First Denosumab Biosimilar In Thailand
Aug 26 (Reuters) - Abbott Laboratories ABT.N:
ABBOTT RECEIVES REGULATORY APPROVAL FOR THE FIRST DENOSUMAB BIOSIMILAR IN THAILAND, EXPANDING ACCESS TO BONE DISEASE TREATMENT
Source text: ID:nPre1QdRca
Further company coverage: ABT.N
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.